Apoptosis in the effector phase of autoimmune diabetes, multiple sclerosis and thyroiditis.
The immune system is unusual in two respects. It produces billions of new cells daily that traffic throughout the body and cells within the system proliferate rapidly following exposure to an infectious agent. Both of these attributes require that cell production be regulated by cell death. Human diseases characterized by accelerated cell death leading to immunodeficiency disorders or by reduced cell death leading to systemic autoimmune diseases have been identified. In certain autoimmune diseases, the immune system directs its powerful cytotoxic effector mechanisms against specialized cells such as oligodendrocytes in multiple sclerosis, the beta cells of the pancreas in diabetes mellitus and thyrocytes in Hashimoto's thyroiditis. In this review, we examine the cytotoxic effector pathways implicated in cell death in organ specific autoimmune disorders.
Ohsako
S
S
Hospital for Special Surgery - Cornell University Medical College, New York, New York 10021, USA.
Elkon
K B
KB
D000818:Animals; D017209:Apoptosis / Q000276:immunology*; D001327:Autoimmune Diseases / Q000276:immunology*; D020169:Caspases / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology*; D004195:Disease Models, Animal; D006801:Humans; D009103:Multiple Sclerosis / Q000276:immunology*; D015398:Signal Transduction / Q000276:immunology; D013967:Thyroiditis, Autoimmune / Q000276:immunology*
D020169:Caspases